Violation Tracker Individual Record
Company:Boehringer Ingelheim Roxane, Inc.
Date:September 22, 2008
Offense Group:government-contracting-related offenses
Primary Offense:False Claims Act and related
Boehringer Ingelheim Roxane, Inc. agreed to pay $1.8 million in settlement of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to pay inflated amounts.
Level of Government:state
Action Type:agency action
Agency:Massachusetts Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Germany
Ownership Structure of Parent:privately held
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.